France Country Drug Report 2018

Key statistics

Most recent estimates and data reported

  EU range
  Year Country data Min. Max.

* PWID — People who inject drugs.

Cannabis
Lifetime prevalence of use - schools (% , Source: ESPAD) 2015 31.5 6.5 36.8
Last year prevalence of use - young adults (%) 2016 21.5 0.4 21.5
Last year prevalence of drug use - all adults (%) 2016 11.1 0.3 11.1
All treatment entrants (%) 2016 62.5 1.0 69.6
First-time treatment entrants (%) 2016 78.0 2.3 77.9
Quantity of herbal cannabis seized (kg) 2016 18206 12 110855
Number of herbal cannabis seizures 2016 31736 62 158810
Quantity of cannabis resin seized (kg) 2016 52735 0 324379
Number of cannabis resin seizures 2016 77466 8 169538
Potency - herbal (% THC) (minimum and maximum values registered) 2016 0 - 28 0 59.90
Potency - resin (% THC) (minimum and maximum values registered) 2016 0 - 70 0 70
Price per gram - herbal (EUR) (minimum and maximum values registered) 2016 7 - 10 0.60 111.10
Price per gram - resin (EUR) (minimum and maximum values registered) 2016 5 - 9.2 0.20 38.00
Cocaine
Lifetime prevalence of use - schools (% , Source: ESPAD) 2015 4 0.9 4.9
Last year prevalence of use - young adults (%) 2014 2.4 0.2 4.0
Last year prevalence of drug use - all adults (%) 2014 1.1 0.1 2.3
All treatment entrants (%) 2016 6.7 0.0 36.6
First-time treatment entrants (%) 2016 5.9 0.0 35.5
Quantity of cocaine seized (kg) 2016 8532 1 30295
Number of cocaine seizures 2016 9480 19 41531
Purity (%) (minimum and maximum values registered) 2016 0 - 89.2 0 99
Price per gram (EUR) (minimum and maximum values registered) 2016 60 - 75 3.00 303.00
Amphetamines
Lifetime prevalence of use - schools (% , Source: ESPAD) 2015 2.3 0.8 6.5
Last year prevalence of use - young adults (%) 2014 0.7 0.0 3.6
Last year prevalence of drug use - all adults (%) 2014 0.3 0.0 1.7
All treatment entrants (%) 2016 0.4 0.2 69.7
First-time treatment entrants (%) 2016 0.4 0.3 75.1
Quantity of amphetamine seized (kg) 2016 274 0 3380
Number of amphetamine seizures 2016 822 3 10388
Purity - amphetamine (%) (minimum and maximum values registered) 2016 n.a. 0 100
Price per gram - amphetamine (EUR) (minimum and maximum values registered) 2016 10 - 20 2.50 76.00
MDMA
Lifetime prevalence of use - schools (% , Source: ESPAD) 2015 2.2 0.5 5.2
Last year prevalence of use - young adults (%) 2014 2.3 0.1 7.4
Last year prevalence of drug use - all adults (%) 2014 0.9 0.1 3.6
All treatment entrants (%) 2016 0.4 0.0 1.8
First-time treatment entrants (%) 2016 0.6 0.0 1.8
Quantity of MDMA seized (tablets) 2016 1236649 0 3783737
Number of MDMA seizures 2016 3461 16 5259
Purity (MDMA mg per tablet) (minimum and maximum values registered) 2016 n.a. 1.90 462
Purity (MDMA % per tablet) (minimum and maximum values registered) 2016 0 - 63 0 88.30
Price per tablet (EUR) (minimum and maximum values registered) 2016 6 - 10 1 26.00
Opioids
High-risk opioid use (rate/1 000) 2015 5.6 0.3 8.1
All treatment entrants (%) 2016 26.1 4.8 93.4
First-time treatment entrants (%) 2016 12.3 1.6 87.4
Quantity of heroin seized (kg) 2016 1080 0 5585
Number of heroin seizures 2016 4312 2 10620
Purity - heroin (%) (minimum and maximum values registered) 2016 0 - 76 0 92
Price per gram - heroin (EUR) (minimum and maximum values registered) 2016 25 - 45 4.00 296.00
Newly diagnosed HIV cases related to Injecting drug use -- aged 15-64 (cases/million population, Source: ECDC) 2016 0.7 0 33.00
HIV prevalence among PWID* (%) 2015 4.7 0 31.50
HCV prevalence among PWID* (%) n.a. n.a. 14.60 82.20
Injecting drug use -- aged 15-64 (cases rate/1 000 population) 2015 2.68 0.10 9.20
Drug-induced deaths -- aged 15-64 (cases/million population) 2014 6.95 1.40 132.30
Health and social responses
Syringes distributed through specialised programmes 2014 12 314 781 22 6469441
Clients in substitution treatment 2016 169750 229 169750
Treatment demand
All entrants 2016 56482 265 119973
First-time entrants 2016 16127 47 39059
All clients in treatment 2016 243000 1286 243000
Drug law offences
Number of reports of offences 2016 218731 775 405348
Offences for use/possession 2016 182161 354 392900

France main page

Methodological note: Analysis of trends is based only on those countries providing sufficient data to describe changes over the period specified. The reader should also be aware that monitoring patterns and trends in a hidden and stigmatised behaviour like drug use is both practically and methodologically challenging. For this reason, multiple sources of data are used for the purposes of analysis in this report. Caution is therefore required in interpretation, in particular when countries are compared on any single measure. Detailed information on methodology and caveats and comments on the limitations in the information set available can be found in the EMCDDA Statistical Bulletin.